An update on antithrombotic therapy in atrial fibrillation patients in long-term ambulatory setting after percutaneous coronary intervention: where do we go from here?

Taylor and Francis Group, Expert Opinion on Pharmacotherapy, 15(22), p. 2033-2051, 2021

Journal article published in 2021 by Jacopo Marazzato, Paolo Verdecchia, Michele Golino, Federico Blasi

Distributing this paper is prohibited by the publisher

Full text: Unavailable

Preprint: archiving forbidden

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by